The Lobcast covers all things invasive lobular carcinoma: from ILC basics to groundbreaking research to heartfelt patient stories. Join Dr. Deviyani Rao as she talks with both experts and patients to demystify this common breast cancer subtype.
Listen in as Dr. Deviyani Rao talks with Front Range ILC patient advocate Carolyn Reuss and Dr. Matthew Sikora about the recent “Lob One for Lobular” fundraising event as well as how smaller philanthropic gifts can have a big impact on research.
Connect with The Lobcast:
- Follow The Lobcast on Instagram, Facebook, and BlueSky
- E-mail thelobcastpodcast@gmail.com with any inquires
Resources an...
Listen in as Dr. Deviyani Rao talks with patient advocate Tracy Cushing about her journey through an ILC diagnosis, how her training as an ER physician impacted her perspective, and the development of the Front Range ILC Patient Advocacy group.
Connect with The Lobcast:
Resources and l...
Listen in as Dr. Deviyani Rao talks with patient advocate Judy Haber about her journey through an ILC diagnosis and how Judy learned to advocate for herself and others with ILC.
Connect with The Lobcast:
Resources and links mentioned:
Listen in as Dr. Deviyani Rao talks with patient advocate Donna Charlevoix and her daughter Evelyn Romine about navigating an ILC diagnosis, patient advocacy and Evelyn’s summer in the Sikora Lab researching ILC.
Connect with The Lobcast:
Resources and links mentioned:
Listen in as Dr. Deviyani Rao talks with patient advocate Carolyn Reuss about her journey through an ILC diagnosis and the many patient advocacy groups that she supports and that have supported her.
Connect with The Lobcast:
Resources and links mentioned:
Listen in as Dr. Deviyani Rao talks with patient advocates Flora Migyanka, Lori Petitti, Tracy Cushing and Donna Charlevoix about what it means to be an ILC patient advocate and their involvement in the many different ILC and breast cancer advocacy groups that help support patients and research.
Connect with The Lobcast:
Listen in as Dr. Deviyani Rao talks with researcher Dr. Steffi Oesterreich and patient advocates Donna Charlevoix and Carolyn Reuss about research on ILC, from where the field started to where researchers hope to go next.
Connect with The Lobcast:
Resources and links mentioned:
Listen in as Dr. Deviyani Rao talks with Dr. Jennifer Diamond and patient advocate Judy Haber about how ILC is identified, diagnosed and treated, what recurrence and metastasis look like in this unique breast cancer type, and the ILC clinical trial landscape.
Connect with The Lobcast:
Listen in as Dr. Deviyani Rao asks Dr. Matthew Sikora and Dr. Tracy Cushing to explain the basics of ILC including why ILC is unique amongst breast cancers as well as what the field currently knows, and doesn’t know, about ILC.
Connect with The Lobcast:
Resources and links mentioned:
Listen in as Dr. Deviyani Rao and Dr. Matthew Sikora chat about a new podcast coming soon: The Lobcast.
The Lobcast aims to be a podcast for the invasive lobular carcinoma (ILC) community and will cover topics on the basics of ILC, ILC research, ILC-related events, and ILC patient stories.
Full episodes to come in August 2026!
Connect with The Lobcast:
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com
Listen to 'The Bobby Bones Show' by downloading the daily full replay.
The official podcast of comedian Joe Rogan.
The Clay Travis and Buck Sexton Show. Clay Travis and Buck Sexton tackle the biggest stories in news, politics and current events with intelligence and humor. From the border crisis, to the madness of cancel culture and far-left missteps, Clay and Buck guide listeners through the latest headlines and hot topics with fun and entertaining conversations and opinions.